Targeting oxidative stress and inflammation in diabetic retinopathy: the role of PPARs
- 1Department of Fundus Diseases and Ophthalmic Surgery, Eye Hospital, China Academy of Chinese Medical Sciences, Beijing 100040, China
Abstract
Diabetic retinopathy (DR) is the leading cause of preventable blindness in working-age adults globally. Current therapies mainly target advanced vascular lesions, leaving early metabolic and inflammatory dysregulation unaddressed. Dysregulated lipid metabolism acts as a critical upstream initiator of DR, converging with oxidative stress and chronic inflammation to form a self-amplifying pathogenic loop driving retinal neurovascular degeneration. Peroxisome proliferator-activated receptors (PPARs) are master transcriptional regulators linking lipid metabolism, oxidative stress, and inflammation. This review systematically delineates the synergistic pathogenic network in DR, comprehensively discusses the pleiotropic retinal protective effects of PPARα and PPARγ, and summarizes the latest advances in PPAR-targeted nano-drug delivery systems that overcome the limitations of traditional agonists. Finally, we highlight key challenges and future directions to advance precision therapy for DR.
Related
- Potential role of resveratrol in abdominal cocoon syndrome: targeting inflammation, oxidative stress, and fibrosis via food-derived bioactive compounds resveratrol for treatment of abdominal cocoon syndrome
- tRF-15:31-Arg-CCT-3-1 Improves Diabetic Kidney Disease by Reducing AATF and Alleviating Mesangial Cell Oxidative Stress and Inflammation.
- Association between the stress hyperglycemia ratio and neovascular glaucoma in patients with proliferative diabetic retinopathy
- Targeting Caveolin-1 Alleviated Diabetic Retinopathy Injury through Protecting Müller Cells from Ferroptosis via the xCT/GPX4 Signaling Pathway
- Hyperglycemic stress aggravates diabetic retinopathy and nephropathy by promoting cilium disassembly via a deacetylation- and methylation-mediated regulatory mechanism
BibTeX
@article{zhang2026targeting,
title = {{Targeting oxidative stress and inflammation in diabetic retinopathy: the role of PPARs}},
author = {Yi-Ge Zhang and Meng-Jiao Zhang and Mei Sun and Jing Xu and Li-Ke Xie and Xiao-Feng Hao},
journal = {International Journal of Ophthalmology},
year = {2026},
month = nov,
doi = {10.18240/ijo.2026.11.19},
url = {https://doi.org/10.18240/ijo.2026.11.19},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Targeting oxidative stress and inflammation in diabetic retinopathy: the role of PPARs
AU - Yi-Ge Zhang
AU - Meng-Jiao Zhang
AU - Mei Sun
AU - Jing Xu
AU - Li-Ke Xie
AU - Xiao-Feng Hao
PY - 2026
DA - 2026/11/02
JO - International Journal of Ophthalmology
DO - 10.18240/ijo.2026.11.19
UR - https://doi.org/10.18240/ijo.2026.11.19
AB - Diabetic retinopathy (DR) is the leading cause of preventable blindness in working-age adults globally. Current therapies mainly target advanced vascular lesions, leaving early metabolic and inflammatory dysregulation unaddressed. Dysregulated lipid metabolism acts as a critical upstream initiator of DR, converging with oxidative stress and chronic inflammation to form a self-amplifying pathogenic loop driving retinal neurovascular degeneration. Peroxisome proliferator-activated receptors (PPARs) are master transcriptional regulators linking lipid metabolism, oxidative stress, and inflammation. This review systematically delineates the synergistic pathogenic network in DR, comprehensively discusses the pleiotropic retinal protective effects of PPARα and PPARγ, and summarizes the latest advances in PPAR-targeted nano-drug delivery systems that overcome the limitations of traditional agonists. Finally, we highlight key challenges and future directions to advance precision therapy for DR.
SN - 2222-3959
SN - 2227-4898
ER -